These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 39195337)
1. Appropriateness of Imaging for Low-Risk Prostate Cancer-Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC). Mercedes R; Head D; Zook E; Eidelman E; Tomaszewski J; Ginzburg S; Uzzo R; Smaldone M; Danella J; Guzzo TJ; Lee D; Belkoff L; Walker J; Reese A; Shah MS; Jacobs B; Raman JD Curr Oncol; 2024 Aug; 31(8):4746-4752. PubMed ID: 39195337 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer. Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883 [TBL] [Abstract][Full Text] [Related]
4. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC. Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692 [TBL] [Abstract][Full Text] [Related]
6. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686 [TBL] [Abstract][Full Text] [Related]
7. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis. Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494 [TBL] [Abstract][Full Text] [Related]
8. Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer? Grant Owens R; Loloi J; Lehman EB; Kaag MG; Raman JD; Merrill SB Urol Oncol; 2021 Jul; 39(7):433.e9-433.e15. PubMed ID: 33610444 [TBL] [Abstract][Full Text] [Related]
9. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer. Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985 [TBL] [Abstract][Full Text] [Related]
10. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748 [TBL] [Abstract][Full Text] [Related]
11. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Huncharek M; Muscat J Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. Risko R; Merdan S; Womble PR; Barnett C; Ye Z; Linsell SM; Montie JE; Miller DC; Denton BT Urology; 2014 Dec; 84(6):1329-34. PubMed ID: 25288575 [TBL] [Abstract][Full Text] [Related]
17. Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre. Haran C; McBean R; Parsons R; Wong D J Med Imaging Radiat Oncol; 2019 Aug; 63(4):495-499. PubMed ID: 30972933 [TBL] [Abstract][Full Text] [Related]
18. Impact of Basso Dias A; Finelli A; Bauman G; Veit-Haibach P; Berlin A; Ortega C; Avery L; Metser U Radiology; 2022 Sep; 304(3):600-608. PubMed ID: 35608445 [TBL] [Abstract][Full Text] [Related]
19. Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort. Talwar R; Friel B; Mittal S; Xia L; Fonshell C; Danella J; Jacobs B; Lanchoney T; Raman J; Tomaszewski J; Trabulsi E; Reese A; Singer EA; Ginzburg S; Smaldone M; Uzzo R; Mucksavage P; Guzzo TJ; Lee DJ Urol Oncol; 2020 Nov; 38(11):846.e17-846.e22. PubMed ID: 32739228 [TBL] [Abstract][Full Text] [Related]
20. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs. Falchook AD; Salloum RG; Hendrix LH; Chen RC Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]